Zenas BioPharma (ZBIO) Current Leases (2023 - 2026)
Zenas BioPharma's (ZBIO) quarterly Current Leases came in at $1.0 million in Q1 2026, up 14.21% year-on-year from $908000.0 in Q1 2025, and down 7.0% quarter-over-quarter from $1.1 million in Q4 2025.
Zenas BioPharma (ZBIO) Current Leases (2023 - 2026) Analysis & Trends
Zenas BioPharma's Current Leases history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- On a quarterly basis, Current Leases rose 14.21% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 14.21% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 42.04% from the prior year.
- Current Leases eased to $1.0 million in Q1 2026 per ZBIO's latest filing, from $1.1 million in the prior quarter.
- Across five years, Current Leases topped out at $1.1 million in Q4 2025 and bottomed at $384000.0 in Q3 2024.
- The 4-year median for Current Leases is $789000.0 (2024), against an average of $774500.0.
- Across the five-year window, Current Leases jumped 60.94% in 2025 and advanced 14.21% in 2026, its largest moves.
- Year by year, Current Leases stood at $556000.0 in 2023, then soared by 41.19% to $785000.0 in 2024, then jumped by 42.04% to $1.1 million in 2025, then fell by 7.0% to $1.0 million in 2026.
- Per Business Quant, the three latest ZBIO Current Leases figures stand at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $618000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 793,000.00 |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | 785,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Dec 31, 2023 | 556,000.00 |